Green tea-based mouthwashes can be considered an alternative to CHX mouthwashes in sustaining oral hygiene, especially because of the added advantages provided by such herbal preparations.
The present review aims at comparing the effectiveness of Acellular Dermal Matrix Allograft (ADMA) with Subepithelial Connective Tissue Graft with Coronally Advanced Flap on the different clinical parameters. Methods: Randomized controlled clinical trials with a follow up of at least 6 months published between 1st January 1980 to 31st July 2019 were identified from MEDLINE, the Cochrane Central Register of Controlled Trials, the National Institutes of Health Trials,Clinical Trials Registry India, Google Scholar and major journals. After a comprehensive search, the articles were independently screened for eligibility by two reviewers. All cross reference lists of the selected studies were screened for any additional papers.Studies who had localised or multiple Miller's Class I or II gingival recession were included.Results: Sixteen articles out of 50 titles were found to meet the eligibility criteria. There was no significant difference between Subepithelial Connective Tissue Graft and ADMA with parameters such as recession height/depth, recession width, probing depth, clinical attachment level and root coverage gain. Although ADMA is expensive, it provides less surgical time, less postoperative pain, no addition of a second surgical site, has uniform thickness and can be used for multiple recession sites which is not possible with Subepithelial Connective Tissue Graft which requires a second surgical site and is technique sensitive.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.